Compare Eli Lilly And Co (LLY) vs ProShares Ultra Semiconductors (USD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs ProShares Ultra Semiconductors — how do they compare? Eli Lilly And Co trades at $1,214.01 (market cap $1.08T), while ProShares Ultra Semiconductors trades at $91.9. The key difference: Eli Lilly And Co pays a 0.57% dividend while ProShares Ultra Semiconductors pays none. Which is the better fit depends on your goals.
| LLY | USD | |
|---|---|---|
Market Cap | $1.08T | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $1.24K | $113.53 |
52-Week Low | $639.43 | $40.97 |
Enterprise Value | $1.13T | — |
Dividend Yield | 0.57% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About ProShares Ultra Semiconductors
USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.
Read more on USD →
